Role of neuropeptide Y in diet-, chemical- and genetic-induced obesity of mice

International Journal of Obesity

Volumn 22, Issue 6, 1998, Pages 506-512

  Hollopeter, G ^a   Erickson, J C ^a   Palmiter, R D ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Gold thioglucose; High fat diet; Lethal yellow agouti; Monosodium glutamate; Neuropeptide Y; UCP DTA

Indexed keywords

AUROTHIOGLUCOSE; DIPHTHERIA TOXIN; GLUTAMATE SODIUM; LEPTIN; NEUROPEPTIDE Y; UNCOUPLING PROTEIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; FEMALE; FOOD INTAKE; GENE MUTATION; HYPOTHALAMUS LESION; LIPID DIET; MALE; MOUSE; MOUSE MUTANT; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENE;

AGOUTI; ANIMALIA; MURINAE;

EID: 0031777999     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800615     Document Type: Article

References (54)

1. Dumont Y, Martel JC, Fournier A, St Pierre S, Quirion R. Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog Neurobiol 1992; 38: 125-67.
2. Colmers WF, Wahlestedt C (eds). The Biology of Neuro-peptide Y and Related Peptides. Humana Press: Totowa, NJ, 1993.
3. Hendry SHC. Organization of Neuropeptide Y Neurons in the Mammalian Central Nervous System. In: Colmers WF, Wahlestedt C (eds). The Biology of Neuropeptide Y and Related Peptides. Humana Press: Totowa, NJ, 1993, 65-135.
4. Fukushima M, Tokunaga K, Lupien J, Kemnitz JW, Bray GA. Dynamic and static phases of obesity following lesions in PVN and VMH. Am J Physiol 1987; 253: R523-R52.
5. Bray GA, York DA, Fisler JS. Experimental obesity: a homeostatic failure due to defective nutrient stimulation of the sympathetic nervous system. Vitam Horm 1989; 45: 1-125.
6. Brady LS, Smith MA, Gold PW, Herkenham M. Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. Neuroendocrinology 1990; 52: 441-447.
7. Kalra SP, Dube MG, Sahu A, Phelps CP, Kalra PS. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc Natl Acad Sci USA 1991; 88: 10931-10935.
8. Morley JE, Levine AS, Gosnell BA, Kneip J, Grace M. Effect of neuropeptide Y on ingestive behaviors in the rat. Am J Physiol 1987; 239: R344-R386.
9. Billington CJ, Briggs JE, Grace M, Levine AS. Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. Am J Physiol 1991; 260: R321-R327.
10. Stanley BG. Neuropeptide Y in Multiple Hypothalamic Sites Controls Eating Behavior, Endocrine, and Autonomic Systems for Body Energy Balance. In: Colmers WF, Wahlestedt (eds). The Biology of Neuropeptide Y and Related Peptides. Humana Press: Totowa, NJ, 1993, 457-498.
11. Stanley BG, Kyrkouli SE, Lampert S, Leibowitz SF. Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides 1986; 7: 1189-1192.
12. Beck B, Stricker KA, Nicolas JP, Burlet C. Chronic and continuous intracerebroventricular infusion of neuropeptide Y in Long-Evans rats mimics the feeding behaviour of obese Zucker rats. Int J Obes 1992; 16: 295-302.
13. Zarjevski N, Cusin I, Vettor R, Rohner JF, Jeanrenaud B. Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 1993; 133: 1753-1758.
14. Tomaszuk A, Simpson C, Williams G. Neuropeptide Y, the hypothalamus and the regulation of energy homeostasis. Horm Res 1996; 46: 53-58.
15. Wang Q, Bing C, Al BK, Mossakowaska DE, Wang XM, McBay DL, Neville WA, Taddayon M, Pickavance L, Dryden S, Thomas ME, McHale MT, Gloyer IS, Wilson S, Buckingham R, Arch JR, Trayhurn P, Williams G. Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat. Diabetes 1997; 46: 335-341.
16. Erickson JC, Clegg KE, Palmiter RD. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 1996; 381: 415-421.
17. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.
18. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Woolf EA, Monroe CA, Tepper RI. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995; 83: 1263-1271.
19. Bray GA, York DA. Hypothalamic and genetic obesity in experimental animals: an autonomie and endocrine hypothesis. Physiol Rev 1979; 59: 719-809.
20. Sanacora G, Kershaw M, Finkelstein JA, White JD. Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation. Endocrinology 1990; 127: 730-737.
21. Wilding JP, Gilbey SG, Bailey CJ, Batt RA, Williams G, Ghatei MA, Bloom SR. Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. Endocrinology 1993; 132: 1939-1944.
22. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269: 546-549.
23. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-546.
24. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540-543.
25. Erickson JC, Hollopeter G, Palmiter RD. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 1996; 274: 1704-1707.
26. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1995; 1: 1311-1314.
27. Frederich RC, Lollmann B, Hamann A, Napolitano RA, Kahn BB, Lowell BB, Flier JS. Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J Clin Invest 1995; 96: 1658-1663.
28. Surwit RS, Feinglos MN, Rodin J, Sutherland A, Petro AE, Opara EC, Kuhn CM, Rebuff'e SM. Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 1995; 44: 645-651.
29. Cummings DE, Brandon EP, Planas JV, Motamed K, Idzerda RL, McKnight GS. Genetically lean mice result from targeted disruption of the RII beta subunit of protein kinase A. Nature 1996; 382: 622-626.
30. Olney JW. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 1969; 164: 719-721.
31. Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT, Trayhurn P. Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett 1996; 387: 113-116.
32. Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG. Identification of targets of leptin action in rat hypothalamus. J Clin Invest 1996; 98: 1101-1106.
33. Yamamoto T, Matsuo S, Ueshima Y, Inoue F, Kinugasa A, Sawada T. Plasma levels of insulin-like growth factor-I are reduced at one week of age in monosodium L-glutamate-treated mice. Endocr J 1993; 40: 461-465.
34. Debons AF, Krimsky I, Maayan ML, Fani K, Jemenez FA. Gold thioglucose obesity syndrome. Fed Proc 1977; 36: 143-147.
35. Lowell BB, Susulic SV, Hamann A, Lawitts JA, Himms HJ, Boyer BB, Kozak LP, Flier JS. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 1993; 366: 740-742.
36. Duhl DM, Vrieling H, Miller KA, Wolff GL, Barsh GS. Neomorphic agouti mutations in obese yellow mice. Nat Genet 1994; 8: 59-65.
37. Siracusa LD. The agouti gene: turned on to yellow. Trends Genet 1994; 10: 423-428.
38. Lu D, Willard D, Patel IR, Kadwell S, Overton L, Cone RD, Kost T, Luther M, Chen W, Woychik RP, Wilkison WO, Cone RD. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 1994; 371: 799-802.
39. Blanchard SG, Harris CO, Ittoop OR, Nichols JS, Parks DJ, Truesdale AT, Wilkison WO. Agouti antagonism of melanocortin binding and action in the B16F10 murine melanoma cell line. Biochemistry 1995; 34: 10406-10411.
40. Michaud EJ, Bultman SJ, Stubbs LJ, Woychik RP. The embryonic lethality of homozygous lethal yellow mice (Ay/Ay) is associated with the disruption of a novel RNA-binding protein. Genes Dev 1993; 7: 1203-1213.
41. Maffei M, Fei H, Lee GII, Dani C, Leroy P, Zhang Y, Proenca R, Negrel R, Ailhaud G, Friedman JM. Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus. Proc Natl Acad USA 1995; 92: 6957-6960.
42. Beck B, Stricker Krongrad A, Burlet A, Nicolas JP, Burlet C. Influence of diet composition on food intake and hypothalamic neuropeptide Y (NPY) in the rat. Neuropeptides 1990; 17: 197-203.
43. Levin BE, Dunn MAA. Dysregulation of arcuate nucleus preproneuropeptide Y mRNA in diet-induced obese rats. Am J Physiol 1997; 272: R1365-R1370.
44. Young JK. Hypothalamic lesions increase neuronal immunoreactivity for neuropeptide Y. Brain Res Bull 1992; 29: 375-380.
45. Young JK, McKenzie JC, Brady LS, Herkenham M. Hypothalamic lesions increase levels of neuropeptide Y mRNA in the arcuate nucleus of mice. Neurosci Lett 1994; 165: 13-17.
46. Marks JL, Waite K, Cameron SD, Blair SC, Cooney GJ. Effects of gold thioglucose on neuropeptide Y messenger RNA levels in the mouse hypothalamus. Am J Physiol 1996; 270: R1208-R1214.
47. Abe M, Saito M, Shimazu T. Neuropeptide Y in the specific hypothalamic nuclei of rats treated neonatally with monosodium glutamate. Brain Res Bull 1990; 24: 289-291.
48. Stricker-Krongrad A, Beck B, Burlet C. Enhanced feeding response to neuropeptide Y in hypothalamic neuropeptide Y-depleted rats. Eur J Pharmacol 1996; 295: 27-34.
49. Kesterson RA, Huszar D, Lynch CA, Simerly RB, Cone RD. Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome. Mol Endocrinol 1997; 11: 630-637.
50. Erickson JC, Ahima RS, Hollopeter G, Flier JS, Palmiter RD. Endocrine function of neuropeptide Y knockout mice. Regulatoiy Peptides 1997; 70: 199-202.
51. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997; 385: 165-168.
52. Ollmann MN, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I, Barsh GS. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 1997; 278: 135-138.
53. Shutter JR, Graham M, Kinsey AC, Scully S, Luthy R, Stark KL. Hypthalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev 1997; 11: 593-602.
54. Schwartz MW, Baskin DG, Bukowski TR, Kuijuper JL, Foster D, Lasser G, Prunkard DE, Porte DJ, Woods SC, Seeley RJ, Weigle DS. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 1996; 45: 531-535.